duke, JT said he will wait till generics launch before he considers introducing AG. He honestly believes that generics don't have enough supply to meet demand. What about amarin's vascepa stockpile that's building at one of their suppliers plants. That fact has been mentioned in one of their past financial filings. I don't know if the supplier has an exclusive with amarin, why not send an email to Elisabeth to confirm. I'll apologize if I'm wrong.
News 
Market Data 
Discover 
